BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Arthritis
,
Stem cell
,
Pharmacogenetics
,
Clofibrate
,
rs7903146
,
FXYD4
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CD123
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Dendritic (plasmacytoid) cell
Basophil of peripheral blood
Vena cava
Transverse colon
Macrophage of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Septicemia due to Klebsiella
Q fever
Disease due to Orthopoxvirus
Streptococcal infectious disease
Systemic lupus erythematosus
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
4-hydroxyestradiol-17 beta
Citric Acid
Rotenone
Deoxycytidine
Procarbazine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
STAB1
HNRNPR
GNB1
TMPRSS11B
SLC45A4
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
A Trifunctional Natural Killer Cell Engager Can Target CD123+ Leukemia.
Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123.
Targeting CD123 in BPDCN: an emerging field.
Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T ce…
Targeting CD123 in hematologic malignancies: identifying suitable patients for targeted therapy.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety and Efficacy of Anti-CD123 CAR-T Therapy in Patients With Refractory/ Relapsed CD123+ Acute M…
A Clinical Research of CD123-Targeted CAR-T in Myeloid Malignancies
Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia
Allogenic CD123-CAR-NK Cells in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia
Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Myelocyti…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ